ALX Oncology Holdings Total Non Current Liabilities 2011-2026 | ALXO

Annual Total Non Current Liabilities ALX Oncology Holdings

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	5.97 M	136 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
5.97 M	136 K	3.05 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Aquestive Therapeutics AQST	90.3 M	$ 4.14	0.36 %	$ 443 M	USA
Arcturus Therapeutics Holdings ARCT	30.4 M	$ 8.41	4.73 %	$ 230 M	Israel
Ardelyx ARDX	50.9 M	$ 6.06	1.94 %	$ 1.46 B	USA
argenx SE ARGX	226 M	$ 752.35	0.79 %	$ 25 B	Niderland
Arcutis Biotherapeutics ARQT	167 M	$ 23.83	0.85 %	$ 3.03 B	USA
Aytu BioScience AYTU	42.1 M	$ 2.65	-1.12 %	$ 16.6 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
BioCardia BCDA	1.3 M	$ 1.2	-0.04 %	$ 8 M	USA
BioCryst Pharmaceuticals BCRX	44.7 M	$ 9.6	6.37 %	$ 1.98 B	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	802 M	$ 9.48	-3.27 %	$ 613 M	USA
BioVie BIVI	62.5 K	$ 1.45	2.09 %	$ 2.14 M	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
BioLineRx Ltd. BLRX	8.22 M	$ 2.32	4.98 %	$ 908 M	Israel
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
BioMarin Pharmaceutical BMRN	635 M	$ 56.49	1.78 %	$ 10.8 B	USA
BioNTech SE BNTX	341 M	$ 92.3	1.23 %	$ 27.2 B	Germany
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
Anavex Life Sciences Corp. AVXL	332	$ 3.04	1.54 %	$ 259 M	USA
BioXcel Therapeutics BTAI	1.4 M	$ 1.16	-2.12 %	$ 14.2 M	USA
Cabaletta Bio CABA	43.9 M	$ 3.2	7.94 %	$ 322 M	USA
Can-Fite BioPharma Ltd. CANF	1.63 M	$ 3.21	4.56 %	$ 6.98 B	Israel
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Catalyst Biosciences CBIO	981 K	$ 19.97	2.94 %	$ 1.78 B	USA
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Codexis CDXS	28.2 M	$ 1.97	7.97 %	$ 172 M	USA
Cerus Corporation CERS	58.1 M	$ 1.91	2.42 %	$ 364 M	USA
Cullinan Management CGEM	277 M	$ 15.4	6.72 %	$ 928 M	USA
Coherus BioSciences CHRS	189 M	$ 1.75	0.87 %	$ 205 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
AstraZeneca PLC AZN	30.8 B	-	-	$ 96.9 B	Britain